ロード中...
Progress in treatment of small-cell lung cancer: role of CPT-11
Small-cell lung cancer (SCLC) accounts for approximately 15% of all cases of lung cancer and is a particularly aggressive form of lung cancer characterised by a poor prognosis, rapid tumour growth, and early metastasis. Roughly, two-thirds of patients with SCLC present with extensive disease (ED) an...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2395289/ https://ncbi.nlm.nih.gov/pubmed/14676791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601456 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|